Current Neuro-Oncology

Volume 23 Number 11
15 June 2021

Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 11, 15 June

Al Feghali KA, Randall JW, Liu DD, Wefel JS, Brown PD, Grosshans DR, McAvoy SA, Farhat MA, Li J, McGovern SL, McAleer MF, Ghia AJ, Paulino AC, Sulman EP, Penas-Prado M, Wang J, de Groot J, Heimberger AB, Armstrong TS, Gilbert MR, Mahajan A, Guha-Thakurta N, Chung C.
Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment.
Neurooncol Adv. 2021 Jun 1, 2021;3(1):vdab073∟. doi: 10.1093/noajnl/vdab073∟. PMID: 34337411∟. Interventional study. ˍ

Chen B, Chen C, Wang J, Teng Y, Ma X, Xu J.
Differentiation of Low-Grade Astrocytoma From Anaplastic Astrocytoma Using Radiomics-Based Machine Learning Techniques.
Front Oncol. 2021 Jun 1, 2021;11:521313∟. doi: 10.3389/fonc.2021.521313∟. PMID: 34141605∟. Observational study. ˍ

Yamaguchi S, Hirata K, Okamoto M, Shimosegawa E, Hatazawa J, Hirayama R, Kagawa N, Kishima H, Oriuchi N, Fujii M, Kobayashi K, Kobayashi H, Terasaka S, Nishijima KI, Kuge Y, Ito YM, Nishihara H, Tamaki N, Shiga T.
Determination of brain tumor recurrence using ¹¹C-methionine positron emission tomography after radiotherapy.
Cancer Sci. 2021 Jun 1, 2021;112(10):4246-4256∟. doi: 10.1111/cas.15001∟. PMID: 34061417∟. Interventional study. ˍ

Mellinghoff IK, Penas-Prado M, Peters KB, Burris HA 3rd, Maher EA, Janku F, Cote GM, de la Fuente MI, Clarke JL, Ellingson BM, Chun S, Young RJ, Liu H, Choe S, Lu M, Le K, Hassan I, Steelman L, Pandya SS, Cloughesy TF, Wen PY.
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.
Clin Cancer Res. 2021 Jun 2, 2021;27(16):4491-4499∟. doi: 10.1158/1078-0432.CCR-21-0611∟. PMID: 34078652∟. Interventional study. ˍ

Detti B, Scoccianti S, Teriaca MA, Maragna V, Lorenzetti V, Lucidi S, Bellini C, Greto D, Desideri I, Livi L.
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients.
Radiol Med. 2021 Jun 3, 2021;126(9):1249-1254∟. doi: 10.1007/s11547-021-01381-5∟. PMID: 34081269∟. Observational study. ˍ

Padovan M, Eoli M, Pellerino A, Rizzato S, Caserta C, Simonelli M, Michiara M, Caccese M, Anghileri E, Cerretti G, Rudà R, Zagonel V, Lombardi G.
Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO).
Cancers (Basel). 2021 Jun 3, 2021;13(11):2773∟. doi: 10.3390/cancers13112773∟. PMID: 34204877∟. Interventional study. ˍ

Salans M, Tibbs MD, Huynh-Le MP, Yip A, Tringale K, Karunamuni R, Xu R, Reyes A, Macari AC, Pan-Weisz T, McDonald CR, Hattangadi-Gluth JA.
Quality of Life Is Independently Associated With Neurocognitive Function in Patients With Brain Tumors: Analysis of a Prospective Clinical Trial.
Int J Radiat Oncol Biol Phys. 2021 Jun 5, 2021;111(3):754-763∟. doi: 10.1016/j.ijrobp.2021.05.134∟. PMID: 34102297∟. Interventional study. ˍ

Yao H, Liu J, Zhang C, Shao Y, Li X, Feng M, Wang X, Gan W, Zhou Y, Huang Y.
Clinical study of apatinib plus temozolomide for the treatment of recurrent high-grade gliomas.
J Clin Neurosci. 2021 Jun 5, 2021;90:82-88∟. doi: 10.1016/j.jocn.2021.05.032∟. PMID: 34275586∟. Interventional study˰ ˍ

Li K, Song H, Wang C, Lin Z, Yi G, Yang R, Ni B, Wang Z, Zhu T, Zhang W, Wang X, Liu Z, Huang G, Liu Y.
The Ependymal Region Prevents Glioblastoma From Penetrating Into the Ventricle via a Nonmechanical Force.
Front Neuroanat. 2021 Jun 7, 2021;15:679405∟. doi: 10.3389/fnana.2021.679405∟. PMID: 34163334∟. Observational study. ˍ

Fangusaro J, Cefalo MG, Garré ML, Marshall LV, Massimino M, Benettaib B, Biserna N, Poon J, Quan J, Conlin E, Lewandowski J, Simcock M, Jeste N, Hargrave DR, Doz F, Warren KE.
Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors.
Front Oncol. 2021 Jun 8, 2021;11:660892∟. doi: 10.3389/fonc.2021.660892∟. PMID: 34168987∟. Interventional study. ˍ

Liu IC, Holtzman AL, Rotondo RL, Indelicato DJ, Gururangan S, Cavaliere R, Carter B, Morris CG, Tavanaiepour D, Rutenberg MS.
Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
J Neurooncol. 2021 Jun 8, 2021;153(3):467-476∟. doi: 10.1007/s11060-021-03783-x∟. PMID: 34105033∟. Observational study. ˍ

Montemurro N, Fanelli GN, Scatena C, Ortenzi V, Pasqualetti F, Mazzanti CM, Morganti R, Paiar F, Naccarato AG, Perrini P.
Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
Clin Neurol Neurosurg. 2021 Jun 8, 2021;207:106735∟. doi: 10.1016/j.clineuro.2021.106735∟. PMID: 34119900∟. Observational study. ˍ

Wach J, Apallas S, Schneider M, Weller J, Schuss P, Vatter H, Herrlinger U, Güresir E.
Mean Platelet Volume/Platelet Count Ratio and Risk of Progression in Glioblastoma.
Front Oncol. 2021 Jun 8, 2021;11:695316∟. doi: 10.3389/fonc.2021.695316∟. PMID: 34178693∟. Observational study. ˍ

Michalski JM, Janss AJ, Vezina LG, Smith KS, Billups CA, Burger PC, Embry LM, Cullen PL, Hardy KK, Pomeroy SL, Bass JK, Perkins SM, Merchant TE, Colte PD, Fitzgerald TJ, Booth TN, Cherlow JM, Muraszko KM, Hadley J, Kumar R, Han Y, Tarbell NJ, Fouladi M, Pollack IF, Packer RJ, Li Y, Gajjar A, Northcott PA.
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.
J Clin Oncol. 2021 Jun 10, 2021;39(24):2685-2697∟. doi: 10.1200/JCO.20.02730∟. PMID: 34110925∟. Interventional study. ˍ

Moiraghi A, Roux A, Peeters S, Pelletier JB, Baroud M, Trancart B, Oppenheim C, Lechapt E, Benevello C, Parraga E, Varlet P, Chrétien F, Dezamis E, Zanello M, Pallud J.
Feasibility, Safety and Impact on Overall Survival of Awake Resection for Newly Diagnosed Supratentorial IDH-Wildtype Glioblastomas in Adults.
Cancers (Basel). 2021 Jun 10, 2021;13(12):2911∟. doi: 10.3390/cancers13122911∟. PMID: 34200799∟. Observational study. ˍ

Child AE, Warren EA, Grosshans DR, Paulino AC, Okcu MF, Ris MD, Mahajan A, Orobio J, Cirino PT, Minard CG, Viana AG, Bick J, Woods SP, Chintagumpala M, Kahalley LS.
Long-term cognitive and academic outcomes among pediatric brain tumor survivors treated with proton versus photon radiotherapy.
Pediatr Blood Cancer. 2021 Jun 11, 2021;68(9):e29125∟. doi: 10.1002/pbc.29125∟. PMID: 34114294∟. Observational study. ˍ

Erker C, Lane A, Chaney B, Leary S, Minturn JE, Bartels U, Packer RJ, Dorris K, Gottardo NG, Warren KE, Broniscer A, Kieran MW, Zhu X, White P, Dexheimer PJ, Black K, Asher A, DeWire M, Hansford JR, Gururangan S, Nazarian J, Ziegler DS, Sandler E, Bartlett A, Goldman S, Shih CS, Hassall T, Dholaria H, Bandopadhayay P, Samson Y, Monje M, Fisher PG, Dodgshun A, Parkin S, Chintagumpala M, Tsui K, Gass D, Larouche V, Broxson E, Garcia Lombardi M, Wang SS, Ma J, Hawkins C, Hamideh D, Wagner L, Koschmann C, Fuller C, Drissi R, Jones BV, Leach J, Fouladi M.
Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry.
Neuro Oncol. 2021 Jun 11, 2022;24(1):141-152∟. doi: 10.1093/neuonc/noab140∟. PMID: 34114629∟. Observational study. ˍ

Liu H, Qin X, Zhao L, Zhao G, Wang Y.
Epidemiology and Survival of Patients With Brainstem Gliomas: A Population-Based Study Using the SEER Database.
Front Oncol. 2021 Jun 11, 2021;11:692097∟. doi: 10.3389/fonc.2021.692097∟. PMID: 34195093∟. Observational study. ˍ

Stadlbauer A, Heinz G, Oberndorfer S, Zimmermann M, Kinfe TM, Buchfelder M, Dörfler A, Kremenevski N, Marhold F.
Physiological MRI of microvascular architecture, neovascularization activity, and oxygen metabolism facilitate early recurrence detection in patients with IDH-mutant WHO grade 3 glioma.
Neuroradiology. 2021 Jun 11, 2022;64(2):265-277∟. doi: 10.1007/s00234-021-02740-9∟. PMID: 34115146∟. Observational study. ˍ

Jiao Y, Wang M, Liu X, Wang J, Wang Z, Luo W, Yu Y, Sun H.
Clinical Features and Prognostic Factors of Pediatric Glioblastoma: Report of 38 Cases.
World Neurosurg. 2021 Jun 12, 2021;153:e105-e111∟. doi: 10.1016/j.wneu.2021.06.033∟. PMID: 34129988∟. Observational study. ˍ

Lucas CG, Devine P, Solomon DA, Giannini C, Reifenberger G, Dahiya S, Caccamo D, Perry A.
Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.
J Neuropathol Exp Neurol. 2021 Jun 12, 2021;80(8):764-768∟. doi: 10.1093/jnen/nlab053∟. PMID: 34128073∟. Case report. ˍ

Besiroglu M, Demir T, Shbair ATM, Yasin AI, Topcu A, Turk HM.
Is the Duration of Temozolomide Predictive for Sequential Bevacizumab Treatment Responses in the Glioblastoma Multiforme Cancer Setting?
J Coll Physicians Surg Pak. 2021 Jun 14, 2021;31(8):932-936∟. doi: 10.29271/jcpsp.2021.08.932∟. PMID: 34320710∟. Observational study. ˍ

Bush NAO, Young JS, Zhang Y, Dalle Ore CL, Molinaro AM, Taylor J, Clarke J, Prados M, Braunstein SE, Raleigh DR, Chang SM, Berger MS, Butowski NA.
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma.
J Neurooncol. 2021 Jun 14, 2021;153(3):447-454∟. doi: 10.1007/s11060-021-03781-z∟. PMID: 34125374∟. Observational study. ˍ

Mandel JJ, Youssef M, Yust-Katz S, Patel AJ, Jalali A, Li Z, Wu J, Ludmir EB, de Groot JF.
IDH mutation status and the development of venous thromboembolism in astrocytoma patients.
J Neurol Sci. 2021 Jun 14, 2021;427:117538∟. doi: 10.1016/j.jns.2021.117538∟. PMID: 34146775∟. Observational study. ˍ

Prabhu AV, Lee M, Galhardo E, Newkirk M, Rodriguez A, Xia F.
Pulsed reduced dose-rate radiotherapy for previously irradiated tumors in the brain and spine.
Surg Neurol Int. 2021 Jun 14, 2021;12:280∟. doi: 10.25259/SNI_589_2020? PMID: 34221611∟. Case report. ˍ

Khaddar S, Bhelekar A, Dale O, Varghese L, Patil VM.
Gemcitabine in Recurrent Meningioma.
South Asian J Cancer. 2021 Jun 15, 2020;9(4):261∟. doi: 10.1055/s-0040-1721178∟. PMID: 34141689∟. Letter to the Editor. ˍ